News

Ideas That Generate Results

According to a new research report by RNCOS entitled, “Global CRISPR/Cas9 Market Outlook 2022”, the global CRISPR/Cas9 market is expected to witness high growth due to increasing usage CRISPR/Cas9 technology for targeted genome editing. Moreover, the increasing potential in the CRISPR/Cas9 industry is also attributed to constantly rising incidences of congenital genetic disorders and expanding drug discovery market. Furthermore, the increasing research and development investments and surging demand for synthetic genes also played a key role. The CRISPR/Cas9 market, in 2016, is expected to reach US$ 270 Million. The CRISPR/Cas9 market is expected to become much more organized and consolidated with an introduction of improved applications such as cell line engineering, gene silencing, cell labeling etc, for better genome editing experiences.
 
The major players in this market include Thermo Fisher Scientific, Lonza, GE Healthcare, Agilent Technologies, GenScript, Horizon Discovery Group, Editas Medicine, CRISPR Therapeutics, and Caribou Biosciences amongst others.
 
Research Analysis and Highlights
 
The report is dispersed across 70 pages and provides an in-depth research and rational analysis of the current status and future prospects of the Global CRISPR/Cas9 Industry. The report also provides a clear picture of the factors driving the industry growth and challenges faced by the industry followed by emerging trends and developments. In addition to this, the study includes industry key player’s mergers and collaborations that have occurred during previous years. The report further highlights segmentation of the CRISPR/Cas9 industry based on applications such as cell line engineering, genetic engineering, GM crops etc,; by end user such as academic & research institutes, pharma or biotech companies, etc, ; and by geography such as North America, Europe, etc., and the individual share of each segment. At the end, with special focus on key players in the market, the research provides valuable information to the investors and debut makers who are looking forward to enter in this market.
 
Some of the salient features of the report include:
 

 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM864.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm